Objective To determine risk factors and causes for mortality during childhood in patients with
infantile spasms (IS). We describe the overall goals of care for those who died. Methods This …

Background and objectives The existing literature indicates a higher risk of mortality among
children with Infantile epileptic spasms syndrome (IESS). Our aim was to find the mortality …

Studies have suggested disparate variables affecting long-term outcomes in patients with
infantile spasms. Using a retrospective chart review, the authors identified 109 patients who …

Summary Purpose: Prior to the United Kingdom Infantile Spasms Study (UKISS), our
practice was to initiate vigabatrin for infantile spasms. However, since then we tend to use …

Background The aims of this systematic review and meta-analysis were to assess (i)
estimates of good neurodevelopmental outcome in infantile spasms (IS),(ii) if …

Mortality in pediatric epilepsy is the subject of this review. Epilepsy in both adults and
children increases the risk of premature death. Conditions that are comorbid with epilepsy …

This study explores the etiology and lead time to treatment for infantile spasm (IS) patients
and their effect on treatment responsiveness, in a limited resource setting. Patients with IS …

Objective. Infantile spasms syndrome is a severe epileptic encephalopathy. Management of
infantile spasms remains challenging because of pharmacoresistant forms and relapsing …

Objective Infantile spasms (IS) represent a severe epileptic encephalopathy presenting in
the first 2 years of life. Recommended first‐line therapies (hormonal therapy or vigabatrin) …

SUMMARY A follow‐up study was made on 200 children (115 boys, 85 girls) who had had
infantile spasms, in order to compare their present condition over the age of six years with …